tlag‽ [Regulatives / Guidelines]

posted by nobody – 2017-12-21 16:18 (2698 d 11:48 ago) – Posting: # 18076
Views: 8,192

...somebody had a look at the ADRs (mostly upper GI-tract-related, therefore the gastroresistant formulation) and said, hey, we have to "quantitate" the quality of the gastroresistant part of the formulations. Let's do tlag!

afaik the SmPC recommends application in fed state, due to better tolerability. The EMA guideline gives no recommendation re. fasted/fed?!

On the other hand: Modified release with one single-dose study only?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
169 visitors (0 registered, 169 guests [including 11 identified bots]).
Forum time: 05:07 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5